Breathe Well Live Well
|
In the Asthma Drug Market, Generic Erosion Will Reduce Sales of Merck/Kyorin's …
Business Wire (press release) The upcoming Pharmacor advisory service entitled Asthma, which will be published soon, also finds that the overall market for asthma therapies will be relatively flat over the next decade, with sales increasing slightly by approximately $200 million … |
View full post on asthma – Google News
|
Aerocrine: UK clinical study demonstrates that asthma tests can identify non …
Business Wire (press release) SOLNA, Sweden–(BUSINESS WIRE)–Aerocrine AB (OMX Nordic Exchange: AERO) announces that a clinical trial published in The American Journal of Respiratory and Critical Care Medicine shows that FeNO-testing is an excellent tool to identify patients … |
View full post on asthma – Google News
|
SkyePharma launches asthma treatment in Germany
Stock Market Wire flutiform® was approved for the treatment of asthma maintenance therapy in Germany by its regulatory authority, Bundesinstitut für Arzneimittel und Medizinprodukte (BfARM), in July. Following the launch offlutiform® in Germany, a milestone of €4.0m is … SkyePharma Launches Flutiform In Germany – Quick Facts |
View full post on asthma – Google News
|
Approval given for SkyePharma's asthma treatment
Stock Market Wire StockMarketWire.com – SkyePharma (LSE SKP) has announced that the UK regulatory authority, the Medicines and Healthcare product Regulatory Agency (MHRA), has granted marketing authorisation for flutiform®, a combination product for the treatment of … SKYEPHARMA PLC : Half Yearly Report |
View full post on asthma – Google News
|
Research and Markets: Asthma Global Clinical Trials Review, H1, 2012
Business Wire (press release) Research and Markets (http://www.researchandmarkets.com/research/bwk37f/asthma_global_clin) has announced the addition of GlobalData's new report &quo. |
View full post on asthma – Google News
|
Aerocrine: BlueCross BlueShield of Minnesota to begin FeNO Coverage in August
Business Wire (press release) Following the transition period, exhaled nitric oxide measurement (CPT code 95012) will be covered for patients with asthma. BlueCross BlueShield of Minnesota is the largest insurance company in the state and provides coverage to approximately 66 … |
View full post on asthma – Google News
|
Research and Markets: Asthma – Pipeline Review, H1 2012
Business Wire (press release) Dublin – Research and Markets (http://www.researchandmarkets.com/research/11929672/asthma_pipeline) has announced the addition of Global Markets Direct's new report "Asthma – Pipeline Review, H1 2012" to their offering. Global Markets Direct's, 'Asthma … |
View full post on asthma – Google News
|
Aerocrine: BlueCross BlueShield of Florida Continues Trend, Retires Negative …
Business Wire (press release) We will be better able to identify patients who will respond to inhaled corticosteroids and even determine in whom we may be able to decrease the doses of asthma controller medications” Aerocrine AB (NASDAQ OMX NORDIC: AERO)(STO:AEROB) announces that … |
View full post on asthma – Google News
|
New Book About Asthma Released by Dr. Gary Epler
Business Wire (press release) BOSTON–(BUSINESS WIRE)–World-renowned Harvard Medical School pulmonary and critical care consultant Dr. Gary Epler extends his critically-acclaimed five-step method for personalized health to asthma with his new book, Asthma: You're the Boss. |
View full post on asthma – Google News
|
Aerocrine: South Carolina Adopts Positive Coverage of Aerocrine's FeNo Testing …
Business Wire (press release) “FeNO testing is a significant advancement in managing the patient with asthma. Since the publication of the American Thoracic Guideline on FeNO, this test should be standard of care in every clinic managing asthma patients. South Carolina adopts positive coverage of Aerocrine's FeNO testing in … |
View full post on asthma – Google News